- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Skin Cancer
Volume 2011 (2011), Article ID 858425, 6 pages
Worldwide Increasing Incidences of Cutaneous Malignant Melanoma
Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, WO64-4024, Silver Spring, MD 20993, USA
Received 20 November 2010; Revised 6 April 2011; Accepted 11 August 2011
Academic Editor: Arash Kimyai-Asadi
Copyright © 2011 Dianne E. Godar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Environmental protection agency, Ultraviolet radiation and Melanoma Vol. IV: Appendix A—Assessing the risks of stratospheric ozone depletion. US EPA 400/1-87/001D. Table 4-1, p. 4-2, December 1987.
- G. C. Roush, M. J. Schymura, and T. R. Holford, “Patterns of invasive melanoma in the Connecticut tumor registry. Is the long-term increase real?” Cancer, vol. 61, no. 12, pp. 2586–2595, 1988.
- R. Doll, P. Payne, and J. A. H. Waterhouse, Eds., Cancer Incidence in Five Continents, Vol. I, Union Internationale Contre le Cancer, Geneva, Switzerland, 1966.
- R. Doll, C. S. Muir, and J. A. H. Waterhouse, Eds., Cancer Incidence in Five Continents, Vol. II, Union Internationale Contre le Cancer, Geneva, Switzerland, 1970.
- J. Waterhouse, C. Muir, P. Correa, and J. Powell, Eds., Cancer Incidence in Five Continents, Volume III, IARC Scientific Publications No. 15, IARC, Lyon, France, 1976.
- J. Waterhouse, C. S. Muir, K. Shanmugaratnam, and J. Powell, Eds., Cancer Incidence in Five Continents, Vol. IV, IARC Scientific Publications No. 42, IARC, Lyon, France, 1982.
- C. S. Muir, J. Waterhouse, T. Mack, J. Powell, and S. L. Whelan, Eds., Cancer Incidence in Five Continents, Vol. V, IARC Scientific Publications No. 88, IARC, Lyon, France, 1987.
- D. M. Parkin, C. S. Muir, S. L. Whelan, Y. -T. Gao, J. Ferlay, and J. Powell, Eds., Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publications No. 120, IARC, Lyon, France, 1992.
- D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond, and J. Young, Eds., Cancer Incidence in Five Continents, Vol. VII, IARC Scientific Publications No. 143, IARC, Lyon, France, 1997.
- D. M. Parkin, S. L. Whelan, J. Ferlay, L. Teppo, and D. B. Thomas, Cancer Incidence in Five Continents, Vol. VIII, IARC Scientific Publications No. 155, IARC, Lyon, France, 2002.
- M. P. Curado, B. Edwards, H. R. Shin, et al., Eds., Cancer Incidence in Five Continents, Vol. IX, IARC Scientific Publications No. 160, IARC, Lyon, France, 2007.
- SEER Database, http://seer.cancer.gov/.
- J. M. Elwood, R. P. Gallagher, G. B. Hill, and J. C. G. Pearson, “Cutaneous melanoma in relation to intermittent and constant sun exposure—the Western Canada melanoma study,” British Journal of Cancer, vol. 35, no. 4, pp. 427–433, 1985.
- D. E. Godar, R. J. Landry, and A. D. Lucas, “Increased UVA exposures and decreased cutaneous Vitamin D3 levels may be responsible for the increasing incidence of melanoma,” Medical Hypotheses, vol. 72, no. 4, pp. 434–443, 2009.
- D. E. Godar, S. P. Wengraitis, J. Shreffler, and D. H. Sliney, “UV doses of Americans,” Photochemistry and Photobiology, vol. 73, no. 6, pp. 621–629, 2001.
- D. E. Godar, “UV doses worldwide,” Photochemistry and Photobiology, vol. 81, no. 4, pp. 736–749, 2005.
- S. Gandini, F. Sera, M. S. Cattaruzza et al., “Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure,” European Journal of Cancer, vol. 41, no. 1, pp. 45–60, 2005.
- V. Beral, S. Evans, and G. Milton, “Malignant melanoma and exposure to fluorescent lighting at work,” The Lancet, vol. 2, no. 8293, pp. 290–293, 1982.
- J. A. MacLaughlin, R. R. Anderson, and M. F. Holick, “Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin,” Science, vol. 216, no. 4549, pp. 1001–1003, 1982.
- A. R. Webb, B. R. deCosta, and M. F. Holick, “Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation,” Journal of Clinical Endocrinology and Metabolism, vol. 68, no. 5, pp. 882–887, 1989.
- J. G. Peak and M. J. Peak, “Comparison of initial yields of DNA-to-protein crosslinks and single-strand breaks induced in cultured human cells by far- and near-ultraviolet light, blue light and X-rays,” Mutation Research, vol. 246, no. 1, pp. 187–191, 1991.
- C. A. Jones, E. Huberman, M. L. Cunningham, and M. J. Peak, “Mutagenesis and cytotoxicity in human epithelial cells by far- and near-ultraviolet radiations: action spectra,” Radiation Research, vol. 110, no. 2, pp. 244–254, 1987.
- G. M. Halliday, N. S. Agar, R. S. Barnetson, H. N. Ananthaswamy, and A. M. Jones, “UV-A fingerprint mutations in human skin cancer,” Photochemistry and Photobiology, vol. 81, no. 1, pp. 3–8, 2005.
- M. Moehrle, M. Soballa, and M. Korn, “UV exposure in cars,” Photodermatology Photoimmunology and Photomedicine, vol. 19, no. 4, pp. 175–181, 2003.
- A. R. Webb, L. Kline, and M. F. Holick, “Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 2, pp. 373–378, 1988.
- M. S. Devgun, C. R. Paterson, B. E. Johnson, and C. Cohen, “Vitamin D nutrition in relation to season and occupation,” American Journal of Clinical Nutrition, vol. 34, no. 8, pp. 1501–1504, 1981.
- J. Reichrath, M. Rech, M. Moeini, E. Meese, W. Tilgen, and M. Seifert, “In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells,” Cancer Biology and Therapy, vol. 6, no. 1, pp. 48–55, 2007.
- J. A. Eisman, D. H. Barkla, and P. J. M. Tutton, “Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3,” Cancer Research, vol. 47, no. 1, pp. 21–25, 1987.
- K. Colston, M. J. Colston, and D. Feldman, “1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture,” Endocrinology, vol. 108, no. 3, pp. 1083–1086, 1981.
- R. J. Frampton, S. A. Omond, and J. A. Eisman, “Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites,” Cancer Research, vol. 43, no. 9, pp. 4443–4447, 1983.
- C. Danielsson, K. Fehsel, P. Polly, and C. Carlberg, “Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues,” Cell Death and Differentiation, vol. 5, no. 11, pp. 946–952, 1998.
- S. Yang, C. Smith, and H. F. DeLuca, “1α,25-dihydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo,” Biochimica et Biophysica Acta, vol. 1158, no. 3, pp. 279–286, 1993.
- S. Yang, C. Smith, J. M. Prahl, X. Luo, and H. F. DeLuca, “Vitamin D deficiency suppresses cell-mediated immunity in vivo,” Archives of Biochemistry and Biophysics, vol. 303, no. 1, pp. 98–106, 1993.
- K. Chida, H. Hashiba, M. Fukushima, T. Suda, and T. Kuroki, “Inhibition of tumor promotion in mouse skin by 1α,25-dihydroxyvitamin D3,” Journal of Cancer Research, vol. 45, no. 11, pp. 5426–5430, 1985.
- M. Berwick, B. K. Armstrong, L. Ben-Porat et al., “Sun exposure and mortality from melanoma,” Journal of the National Cancer Institute, vol. 97, no. 3, pp. 195–199, 2005.
- A. E. Millen, M. A. Tucker, P. Hartge et al., “Diet and melanoma in a case-control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 6, pp. 1042–1051, 2004.